| The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people F Salaffi, M Carotti, S Gasparini, M Intorcia, W Grassi Health and quality of life outcomes 7, 1-12, 2009 | 458 | 2009 |
| Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town G Maio, P D'Argenio, T Stroffolini, A Bozza, L Sacco, ME Tosti, M Intorcia, ... Journal of hepatology 33 (1), 116-120, 2000 | 198 | 2000 |
| GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates P Hadji, V Claus, V Ziller, M Intorcia, K Kostev, T Steinle Osteoporosis international 23, 223-231, 2012 | 149 | 2012 |
| Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis L Karlsson, J Lundkvist, E Psachoulia, M Intorcia, O Ström Osteoporosis International 26, 2401-2411, 2015 | 98 | 2015 |
| GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab P Hadji, I Kyvernitakis, PH Kann, C Niedhart, LC Hofbauer, H Schwarz, ... Osteoporosis international 27, 2967-2978, 2016 | 61 | 2016 |
| A retrospective longitudinal database study of persistence and compliance with treatment of osteoporosis in Hungary P Lakatos, I Takács, I Marton, E Tóth, C Zoltan, Z Lang, E Psachoulia, ... Calcified tissue international 98, 215-225, 2016 | 44 | 2016 |
| Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany I Diel, S Ansorge, D Hohmann, C Giannopoulou, D Niepel, M Intorcia Supportive Care in Cancer 28, 5223-5233, 2020 | 34 | 2020 |
| Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modelling approach MA Cimmino, G Leardini, F Salaffi, M Intorcia, A Bellatreccia, D Dupont, ... Clinical and Experimental Rheumatology-Incl Supplements 29 (4), 633, 2011 | 33 | 2011 |
| Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States Y Qian, D Bhowmik, C Bond, S Wang, S Colman, RK Hernandez, ... Cancer Medicine 6 (7), 1523-1530, 2017 | 30 | 2017 |
| Examination of burden of skeletal-related events in patients naive to denosumab and intravenous bisphosphonate therapy in bone metastases from solid tumors population D Bhowmik, X Song, M Intorcia, S Gray, N Shi Current medical research and opinion 35 (3), 513-523, 2019 | 26 | 2019 |
| Bone complications in patients with multiple myeloma in five European countries: A retrospective patient chart review MV Mateos, L Fink, N Koneswaran, M Intorcia, C Giannopoulou, D Niepel, ... BMC cancer 20, 1-13, 2020 | 24 | 2020 |
| An outbreak of vaccination panic P D'Argenio, A Citarella, M Intorcia, G Aversano Vaccine 14 (13), 1289-1290, 1996 | 24 | 1996 |
| A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America N Raje, GD Roodman, W Willenbacher, K Shimizu, R García-Sanz, ... Journal of medical economics 21 (5), 525-536, 2018 | 23 | 2018 |
| Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database D Bhowmik, DM Hines, M Intorcia, RL Wade Journal of medical economics 21 (6), 622-628, 2018 | 21 | 2018 |
| Humanistic and economic burden of geographic atrophy: a systematic literature review SP Sarda, A Heyes, M Bektas, T Thakur, W Chao, M Intorcia, S Wronski, ... Clinical Ophthalmology, 4629-4644, 2021 | 16 | 2021 |
| Prevalence of renal impairment in patients with multiple myeloma: analysis of real-world database D Bhowmik, Y Qian, TC Bond, X Wang, S Colman, RK Hernandez, ... Value in Health 19 (3), A141, 2016 | 15 | 2016 |
| Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates T Petranova, M Boyanov, A Shinkov, R Petkova, M Intorcia, E Psachoulia Archives of Osteoporosis 13, 1-11, 2018 | 10 | 2018 |
| Healthcare resource utilisation associated with skeletal‐related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study J Ashcroft, I Duran, H Hoefeler, V Lorusso, D Lueftner, M Campioni, ... European Journal of Haematology 100 (5), 479-487, 2018 | 10 | 2018 |
| Baseline characteristics and changes in bone mineral density T-scores of Bulgarian women with postmenopausal osteoporosis receiving denosumab in routine clinical practice M Boyanov, A Shinkov, E Psachoulia, M Intorcia, R Petkova Drugs in R&D 17, 125-132, 2017 | 10 | 2017 |
| Real-Life Rates of Disease Monitoring in Clinical Practice in Europe: The “Unmet Needs in CML and Ph+ ALL”(UNIC) Study. E Morra, M Michallet, J Steegmann, DM Costa, G Ossenkoppele, ... Blood 110 (11), 1959, 2007 | 9 | 2007 |
Fausto SalaffiProfessore Associato di Reumatologia在 univpm.it 的电子邮件经过验证
